Stocksigma LogoStocksigma Logo

Emcure Pharmaceuticals Reports Strong Q2 FY27 With Revenue Up 24.3% YoY

Emcure Pharmaceuticals reported strong consolidated Q2 FY27 results, with revenue from operations growing 24.3% YoY (9.3% QoQ) to INR 28,205 Mn, driven by

Emcure Pharmaceuticals Reports Strong Q2 FY27 With Revenue Up 24.3% YoY

Emcure Pharmaceuticals Ltd 路 Outcome 路 03 Nov 2026, 7:14 pm

Emcure Pharmaceuticals Reports Strong Q2 FY27 With Revenue Up 24.3% YoY Emcure Pharmaceuticals reported strong consolidated Q2 FY27 results, with revenue from operations growing 24.3% YoY (9.3% QoQ) to INR 28,205 Mn, driven by a 34.5% YoY rise in international business to INR 16,652 Mn and 12.0% YoY growth in domestic sales to INR 11,553 Mn. EBITDA increased 30.9% YoY to INR 5,748 Mn, expanding EBITDA margin by 103 bps YoY to 20.4%. Profit after tax climbed 29.3% YoY to INR 3,251 Mn with an 11.5% margin. As of 30th Sep'26, net debt stood at INR 13,171 Mn.

Original exchange filing (PDF)

More announcements from Emcure Pharmaceuticals Ltd

All Emcure Pharmaceuticals Ltd announcements